A human organoid system that self-organizes to recapitulate growth and differentiation of a benign mammary tumor.
epithelial tube
lumen formation
mammary gland
organoids
usual ductal hyperplasia
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
04 06 2019
04 06 2019
Historique:
pubmed:
19
5
2019
medline:
24
3
2020
entrez:
19
5
2019
Statut:
ppublish
Résumé
As 3D culture has become central to investigation of tissue biology, mammary epithelial organoids have emerged as powerful tools for investigation of epithelial cell polarization and carcinogenesis. However, most current protocols start from single cells suspended in Matrigel, which can also restrict cell differentiation and behavior. Here, we show that the noncancerous mammary cell line HMT-3522 S1, when allowed to spontaneously form cell aggregates ("spheroids") in medium without Matrigel, switches to a collective growth mode that recapitulates many attributes of "usual ductal hyperplasia" (UDH), a common benign mammary lesion. Interestingly, these spheroids undergo a complex maturation process reminiscent of embryonic development: solid-cell cords form their own basement membrane, grow on the surface of initially homogeneous cell aggregates, and form asymmetric lumina lined by two distinct cell types that express basal and luminal cytokeratins. This sequence of events provides a cellular mechanism that explains how the characteristic crescent-shaped, asymmetrical lumina form in UDH. Our results suggest that HMT-3522 S1 spheroids are useful as an in vitro model system to study UDH biology, glandular lumen formation, and stem cell biology of the mammary gland.
Identifiants
pubmed: 31101720
pii: 1702372116
doi: 10.1073/pnas.1702372116
pmc: PMC6561274
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11444-11453Subventions
Organisme : NCI NIH HHS
ID : P01 CA139980
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA164448
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM131753
Pays : United States
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Dev Biol. 1999 Dec 1;216(1):114-34
pubmed: 10588867
J Pathol. 2002 Dec;198(4):458-67
pubmed: 12434415
Semin Diagn Pathol. 2004 Feb;21(1):10-7
pubmed: 15074554
N Engl J Med. 2005 Jul 21;353(3):229-37
pubmed: 16034008
J Cell Biol. 2007 Mar 12;176(6):779-86
pubmed: 17353356
Dev Biol. 2007 Jun 1;306(1):193-207
pubmed: 17448457
Annu Rev Pathol. 2008;3:313-39
pubmed: 18039125
Histopathology. 2007 Dec;51(6):814-23
pubmed: 18042070
Dev Cell. 2008 Apr;14(4):570-81
pubmed: 18410732
Ann R Coll Surg Engl. 1950 Feb;6(2):99-119
pubmed: 19309885
Histochem Cell Biol. 2010 Feb;133(2):213-21
pubmed: 19937336
Semin Diagn Pathol. 2010 Feb;27(1):5-12
pubmed: 20306826
J Cell Sci. 2012 Jun 1;125(Pt 11):2638-54
pubmed: 22344263
Semin Cell Dev Biol. 2012 Jul;23(5):567-73
pubmed: 22426022
PLoS One. 2012;7(11):e49221
pubmed: 23155468
Breast Cancer Res. 2013 Mar 18;15(2):R25
pubmed: 23506684
PLoS One. 2013 Apr 26;8(4):e62019
pubmed: 23637952
Semin Cell Dev Biol. 2014 Jul;31:124-31
pubmed: 24747369
Breast Cancer Res. 2014 Dec 03;16(6):487
pubmed: 25467960
Development. 2015 Mar 15;142(6):1028-42
pubmed: 25758218
Breast Cancer Res Treat. 1985;5(1):57-65
pubmed: 2983798
Cancer Res. 1988 May 1;48(9):2432-9
pubmed: 3356007
In Vitro Cell Dev Biol. 1987 Mar;23(3):181-8
pubmed: 3558253
J Natl Cancer Inst. 1971 Jan;46(1):113-20
pubmed: 5101993
J Embryol Exp Morphol. 1983 Feb;73:39-57
pubmed: 6875464
Semin Cancer Biol. 1995 Jun;6(3):175-84
pubmed: 7495986
Methods Enzymol. 1994;245:535-56
pubmed: 7760750